JP Morgan Chase’s Juniper Pharmaceuticals, Inc. Common Stock JNP Stock Holding History

JP Morgan Chase’s Portfolio JNP Stock Details JNP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-16,430	Closed	-$143K	–	5971
2018 Q2	$143K	Buy	+16,430	New	+$148K	﹤0.01%	4713

JP Morgan Chase's JNP Position: Q3 2018 in Review

JP Morgan Chase sold out of Juniper Pharmaceuticals, Inc. Common Stock (JNP) in Q3 2018, closing a stake of 16,430 shares — an estimated $143K sold.

JP Morgan Chase first reported a position in JNP in Q2 2018 and held it in 1 quarter. The position peaked at $143K in Q2 2018. 0 funds tracked by Wall St. Rank hold JNP as of Q3 2018.

JP Morgan Chase reported no remaining Juniper Pharmaceuticals, Inc. Common Stock position as of Q3 2018 after selling out during the quarter.
JP Morgan Chase sold 16,430 Juniper Pharmaceuticals, Inc. Common Stock shares in Q3 2018, an estimated $143K.
JP Morgan Chase first reported a position in Juniper Pharmaceuticals, Inc. Common Stock in Q2 2018 and held it in 1 quarter.
JP Morgan Chase's Juniper Pharmaceuticals, Inc. Common Stock position peaked at $143K in Q2 2018.
0 funds tracked by Wall St. Rank held Juniper Pharmaceuticals, Inc. Common Stock as of Q3 2018.

Based on JP Morgan Chase's 13F filing for Q3 2018, filed 7 Nov 2018.